Fig. 2From: Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in NigeriaVariation of haemoglobin concentration between enrolment and third trimester (36–40 weeks gestation)Back to article page